Novozymes A/S
NSIS-B
Rang in aandelen
#803
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Aandeelprijs
$73.15
Marktkapitalisatie
$30.18B
Verandering (1 dag)
-0.19%
Verandering (1 jaar)
28.23%
Land
DK
Handel Novozymes A/S (NSIS-B)
Categorie
Basic Materials
Marktkapitalisatie van Novozymes A/S(NSIS-B)
Marktkapitalisatie: $30.18B
Vanaf October 2026 heeft Novozymes A/S een marktkapitalisatie van $30.18B. Dit maakt Novozymes A/S volgens onze gegevens het 803rd meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Novozymes A/S van 2000 tot 2026
NSIS-B vergeleken met de top 5 populairste stocks
